subha veeramani

https://lnkd.in/gAfFdwE9 Article Title: Therapeutic applications of nanozymes and their role in cardiovascular disease Author(s): Naima Nashat and Zeshan Haider Journal: International Journal of Nanomaterials, Nanotechnology and Nanomedicine Journal ISSN: 2455-3492 Abstract: Enzyme mimetic is an increasing pull to overcome the limitations on natural enzymes. Enzyme mimicking is done with the help of nanozymes. Nanozymes contain nonmaterial which have enzyme-like activity; this similar activity attracts the researchers. Nanozymes studies showed that they are exceptional in many aspects, such as robustness to a harsh environment, long term storage, easy mass production, and high stability. In the field of biomedical technology, nanozymes have exhibited advantages to diagnose and treat disease. Nanozymes used to treat many therapeutics affect antiinflammatory, anti-ageing effects, neuroprotection, cytoprotection, dental biofilms, antioxidation, and antithrombotic effects. However, to broaden the applications of nanozymes, it is synergistically important to combine the activity of enzymes with properties of nanoscale such as optics, magnetic, mechanics, and electrics. Many types of enzymes have been reported, and their applications in Environmental remediation, therapeutics, and biosensor development. Compare with natural enzymes, current research on applications of nanozymes is tranquil somewhat limited. This uncertain issue will be the next borderline for promotes applications. #Chemistry #OrganicChemistry #InorganicChemistry #PhysicalChemistry #AnalyticalChemistry #Biochemistry #TheoreticalChemistry #EnvironmentalChemistry #ChemicalEngineering #Peertechz #PeertechzPublications #PolymerChemistry #MedicinalChemistry #IndustrialChemistry #GreenChemistry #ChemicalSynthesis #ChemicalKinetics #Spectroscopy #Electrochemistry #Nanochemistry #SurfaceChemistry #QuantumChemistry #ChemicalBonding #Thermodynamics #ChemicalCatalysis #SupramolecularChemistry #MaterialsChemistry

#paraneoplasticneurologicalsyndromes #CV2 #CRMP5 #antibody An overview on CV2/CRMP5 antibody-associated paraneoplastic neurological syndromes https://lnkd.in/gYPyT362 Paraneoplastic neurological syndrome refers to certain malignant tumors that have affected the distant nervous system and caused corresponding dysfunction in the absence of tumor metastasis. Patients with this syndrome produce multiple antibodies, each targeting a different antigen and causing different symptoms and signs. The CV2/collapsin response mediator protein 5 (CRMP5) antibody is a major antibody of this type. It damages the nervous system, which often manifests as limbic encephalitis, chorea, ocular manifestation, cerebellar ataxia, myelopathy, and peripheral neuropathy. Detecting CV2/CRMP5 antibody is crucial for the clinical diagnosis of paraneoplastic neurological syndrome, and anti-tumor and immunological therapies can help to alleviate symptoms and improve prognosis. However, because of the low incidence of this disease, few reports and no reviews have been published about it so far. This article intends to review the research on CV2/CRMP5 antibody-associated paraneoplastic neurological syndrome and summarize its clinical features to help clinicians comprehensively understand the disease. Additionally, this review discusses the current challenges that this disease poses, and the application prospects of new detection and diagnostic techniques in the field of paraneoplastic neurological syndrome, including CV2/CRMP5-associated paraneoplastic neurological syndrome, in recent years.